US Stock MarketDetailed Quotes
OFIX Orthofix Medical
- 15.460
- -0.080-0.51%
Close Jul 19 16:00 ET
- 15.360
- -0.100-0.65%
Post 18:42 ET
580.20MMarket Cap-4601P/E (TTM)
15.706High15.270Low209.22KVolume15.540Open15.540Pre Close3.23MTurnover0.57%Turnover RatioLossP/E (Static)37.53MShares21.60052wk High1.02P/B563.53MFloat Cap9.57552wk Low--Dividend TTM36.45MShs Float74.440Historical High--Div YieldTTM2.80%Amplitude5.875Historical Low15.445Avg Price1Lot Size
Orthofix Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.65%188.61M | 62.06%746.64M | 63.97%200.42M | 61.41%184.01M | 58.39%187.02M | 64.64%175.2M | -0.81%460.71M | -2.27%122.23M | 1.39%114M | -2.74%118.07M |
| Operating revenue | 7.65%188.61M | 62.06%746.64M | 63.97%200.42M | 61.41%184.01M | 58.39%187.02M | 64.64%175.2M | -0.81%460.71M | -2.27%122.23M | 1.39%114M | -2.74%118.07M |
| Cost of revenue | -5.41%61.37M | 110.75%260.37M | 92.98%63.79M | 110.13%64.24M | 113.50%67.47M | 129.09%64.88M | 7.51%123.54M | -0.60%33.05M | 8.01%30.57M | 15.16%31.6M |
| Gross profit | 15.33%127.24M | 44.22%486.27M | 53.21%136.63M | 43.56%119.76M | 38.26%119.55M | 41.27%110.33M | -3.55%337.17M | -2.87%89.18M | -0.83%83.42M | -7.97%86.47M |
| Operating expense | -8.88%151.18M | 70.64%610.63M | 54.40%151.23M | 62.17%140.64M | 72.73%152.85M | 95.93%165.91M | 5.16%357.84M | 10.54%97.95M | 2.31%86.73M | -0.34%88.49M |
| Selling and administrative expenses | -7.65%131.69M | 71.77%530.4M | 56.01%132.28M | 63.25%122.08M | 76.18%133.43M | 94.11%142.6M | 6.23%308.78M | 12.52%84.79M | 3.28%74.78M | 0.08%75.73M |
| -Selling and marketing expense | 6.67%100.04M | 68.58%385.74M | 64.77%97.75M | 71.20%94.95M | 65.72%99.25M | 73.25%93.79M | 3.39%228.81M | 3.90%59.32M | -1.13%55.46M | 4.45%59.89M |
| -General and administrative expense | -35.16%31.65M | 80.90%144.66M | 35.59%34.54M | 40.44%27.14M | 115.68%34.18M | 152.54%48.81M | 15.30%79.97M | 39.47%25.47M | 18.45%19.32M | -13.58%15.85M |
| Research and development costs | -16.37%19.49M | 63.52%80.23M | 44.02%18.94M | 55.40%18.56M | 52.25%19.42M | 107.88%23.31M | -1.12%49.07M | -0.69%13.15M | -3.37%11.94M | -2.77%12.76M |
| Operating profit | 56.93%-23.94M | -501.55%-124.35M | -66.42%-14.6M | -532.12%-20.88M | -1,546.83%-33.3M | -745.07%-55.58M | -322.93%-20.67M | -373.46%-8.77M | -409.72%-3.3M | -139.18%-2.02M |
| Net non-operating interest income expense | -253.61%-4.56M | -570.11%-8.63M | -1,865.07%-4.5M | -468.95%-1.58M | -211.06%-1.27M | -243.73%-1.29M | 29.89%-1.29M | 47.60%-229K | 36.03%-277K | 26.00%-407K |
| Non-operating interest expense | 253.61%4.56M | 570.11%8.63M | 1,865.07%4.5M | 468.95%1.58M | 211.06%1.27M | 243.73%1.29M | -29.89%1.29M | -47.60%229K | -36.03%277K | -26.00%407K |
| Other net income (expense) | -92.89%-6.67M | -468.95%-15.7M | -246.82%-2.95M | -2.38%-5.93M | -161.29%-3.35M | -234.92%-3.46M | 120.32%4.25M | 116.26%2.01M | -298.35%-5.79M | 9,498.25%5.47M |
| Special income (charges) | -30.53%-5.4M | -299.31%-14.76M | -63.59%-3.72M | -43.72%-3.57M | -138.47%-3.33M | -218.15%-4.13M | 142.10%7.4M | 81.89%-2.27M | -841.49%-2.48M | 1,069.02%8.66M |
| -Less：Restructuring and merger&acquisition | 30.53%5.4M | 84.30%-2.7M | ---600K | 18.86%-800K | 87.87%-1.3M | 175.16%4.13M | -381.12%-17.2M | --0 | 57.13%-986K | -580.25%-10.71M |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | 78.21%17.46M | 89.97%4.32M | 25.94%4.37M | 125.89%4.63M | ---- | 4.14%9.8M | 13.47%2.27M | 76.59%3.47M | -16.93%2.05M |
| Other non- operating income (expenses) | -288.46%-1.27M | 70.22%-938K | -82.13%766K | 28.66%-2.36M | 99.37%-20K | 172.22%676K | 5.77%-3.15M | 2,216.76%4.29M | -84.91%-3.31M | -435.65%-3.19M |
| Income before tax | 41.70%-35.17M | -739.71%-148.68M | -215.57%-22.05M | -202.87%-28.39M | -1,346.48%-37.92M | -1,274.50%-60.33M | -31.20%-17.71M | 27.26%-6.99M | -269.70%-9.37M | -34.83%3.04M |
| Income tax | 39.28%851K | 32.94%2.72M | 66.67%125K | -64.88%472K | 172.69%1.51M | 760.56%611K | -91.79%2.04M | -99.68%75K | 469.23%1.34M | -75.40%553K |
| Net income | 40.89%-36.02M | -666.60%-151.4M | -213.99%-22.17M | -169.29%-28.86M | -1,684.01%-39.43M | -1,266.32%-60.94M | 48.54%-19.75M | 78.48%-7.06M | -393.60%-10.72M | 2.85%2.49M |
| Net income continuous Operations | 40.89%-36.02M | -666.60%-151.4M | -213.99%-22.17M | -169.29%-28.86M | -1,684.01%-39.43M | -1,266.32%-60.94M | 48.54%-19.75M | 78.48%-7.06M | -393.60%-10.72M | 2.85%2.49M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 40.89%-36.02M | -666.60%-151.4M | -213.99%-22.17M | -169.29%-28.86M | -1,684.01%-39.43M | -1,266.32%-60.94M | 48.54%-19.75M | 78.48%-7.06M | -393.60%-10.72M | 2.85%2.49M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 40.89%-36.02M | -666.60%-151.4M | -213.99%-22.17M | -169.29%-28.86M | -1,684.01%-39.43M | -1,266.32%-60.94M | 48.54%-19.75M | 78.48%-7.06M | -393.60%-10.72M | 2.85%2.49M |
| Basic earnings per share | 44.44%-0.95 | -320.41%-4.12 | -68.57%-0.59 | -45.28%-0.77 | -991.67%-1.07 | -677.27%-1.71 | 49.74%-0.98 | 78.79%-0.35 | -381.82%-0.53 | 0.00%0.12 |
| Diluted earnings per share | 44.44%-0.95 | -320.41%-4.12 | -68.57%-0.59 | -45.28%-0.77 | -991.67%-1.07 | -677.27%-1.71 | 49.74%-0.98 | 78.79%-0.35 | -381.82%-0.53 | 0.00%0.12 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg